RTI Biologics (RTIX): Q3 EPS of $0.05 beats by $0.01. Revenue of $44.6M (+10.2% Y/Y) in-line. (PR)

|About: RTI Surgical, Inc. (RTIX)|By:, SA News Editor
RTI Biologics (RTIX): Q3 EPS of $0.05 beats by $0.01. Revenue of $44.6M (+10.2% Y/Y) in-line. (PR)